Dr. Reddy's Laboratories Limited (RDY) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in India, listed on NYSE. Market cap 10.16B USD. 52-week range 11.36 to 15.67 USD. Trailing P/E 27.7. Data as of 2026-10-09.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with ...